Objective: To analyse clinical data on patients with schizophrenia on admission to acute care and 6 months later in order to identify factors associated with frequent hospitalisations and poor outcome.
Method: Information was collected from the medical records of 99 patients with schizophrenia consecutively admitted to acute care in hospital or by community based 24 h Crisis Teams and prospectively studied for 6 months.
Results: One-quarter of patients were being admitted to acute care within 3 months of their last hospital discharge and only 34 patients were compliant with their neuroleptic medication 3 months prior to the index admission. Twenty-one patients were managed entirely by the Crisis Teams, 27 patients received inpatient care only and the remainder (n = 51) had both types of acute care. Six months after admission, 42 patients had been discharged and did not require further acute care, 29 patients had been re-admitted at least once and three patients had been transferred to an inpatient rehabilitation unit and, therefore, remained in hospital over the entire period. Of the remaining 25 patients, one committed suicide 2 months after discharge and the other patients were not contactable by Community Mental Health Teams at the 2 and/or 6 month follow up.
Conclusions: Some of the factors associated with relapse identified in the present study were non-compliance with medication, stress, inadequate social support and substance abuse. The poor outcome in patients with frequent relapses emphasises the need to reduce the occurrences of schizophrenic symptoms to provide a better quality of life. The 25% of patients dropping out of care soon after a relapse indicates that more should be done to engage these people in long-term treatment programs.
References
1.
LindstromEJonssonDvon KnorringL.Health economic aspects on the treatment of schizophrenia. In: BrunelloNRacagniGMendlewiczJ, eds. Critical Issues in the Treatment of Schizophrenia. Basel: Karger, 1995; 182–192.
2.
RuppAKeithSJThe costs of schizophrenia. Assessing the burden. Psychiatric Clinics of North America1993; 16:413–423.
3.
HaywoodTWKravitzHMGrossmanLSCavanaughJLJrDavisJMLewisDAPredicting the ‘revolving door’ phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. American Journal of Psychiatry1995; 152:856–861.
4.
OwenRRFischerEPBoothBMCuffelBJMedication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services1996; 47:853–858.
5.
American Psychiatric Association.Practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry1997; 154:1–63.
6.
McGlashanTHFentonWSSubtype progression and pathophysiologic deterioration in early schizophrenia. Schizophrenia Bulletin1993; 19:71–84.
7.
KelleyMEGilbertsonMMoutonAvan KammenDPDeterioration in premorbid functioning in schizophrenia: A developmental model of negative symptoms in drug-free patients. American Journal of Psychiatry1992; 149:1543–1548.
8.
BilderRMLipschutzBroch LReiterGGeislerSHMayerhoffDILiebermanJAIntellectual deficits in first-episode schizophrenia: Evidence for progressive deterioration. Schizophrenia Bulletin1992; 18:437–448.
9.
CaroneBJHarrowMWestermeyerJFPosthospital course and outcome in schizophrenia. Archives of General Psychiatry1991; 48:247–253.
10.
LehmanAFEvaluating outcomes of treatments for persons with psychotic disorders. Journal of Clinical Psychiatry1996; 57(Suppl. 11):61–67.
11.
ChandlerDMeiselJHuTWMcGowenMMadisonK.Client outcomes in a three-year controlled study of an integrated service agency model. Psychiatric Services1996; 47:1337–1343.
12.
WolffNHelminiakTWMorseGACalsynRJKlinkenbergWDTrustyMLCost-effectiveness evaluation of three approaches to case management for homeless mentally ill clients. American Journal of Psychiatry1997; 154:341–348.
13.
BarryKLFlemingMFGreenleyJWidlakPKroppSMcKeeD.Assessment of alcohol and other drug disorders in the seriously mentally ill. Schizophrenia Bulletin1995; 21:313–321.
14.
DavisJMComparative doses and costs of antipsychotic medication. Archives of General Psychiatry1976; 33:858–861.
15.
GuptaSHendricksSKenkelAMBhatiaSCHaffkeEARelapse in schizophrenia: Is there a relationship to substance abuse?Schizophrenia Research1996; 20:153–156.
16.
Kozaric-KovacicDFolnegovic-SmalcVFolnegovicZMaruicA.Influence of alcoholism on the prognosis of schizophrenic patients. Journal of Studies in Alcohol1995; 56:622–627.
17.
MenezesPRJohnsonSThornicroftGDrug and alcohol problems among individuals with severe mental illness in south London. British Journal of Psychiatry1996; 168:612–619.
18.
NarrowWERegierDARaeDSManderscheidRWLockeBZUse of services by persons with mental and addictive disorders. Findings from the National Institute of Mental Health Epidemiologic Catchment Area Program. Archives of General Psychiatry1993; 50:95–107.
19.
D'MelloDABoltzMKMsibiB.Relationship between concurrent substance abuse in psychiatric patients and neuroleptic dosage. American Journal of Drug and Alcohol Abuse1995; 21:257–265.
20.
RuscherSMde WitRMazmanianD.Psychiatric patients’ attitudes about medication and factors affecting noncompliance. Psychiatric Services1997; 48:82–85.
21.
WeidenPRapkinBMottTRating of Medication Influences (ROMI) scale in schizophrenia. Schizophrenia Bulletin1994; 20:297–310.
22.
DavisJMKaneJMMarderSRDose response of prophylactic antipsychotics. Journal of Clinical Psychiatry1993; 54(Suppl.):24–30.
23.
SmithJHuckerS.Schizophrenia and substance abuse. British Journal of Psychiatry1994; 164:13–21.
24.
DrakeREMcLaughlinPPepperPMinkoffK.Dual diagnosis of major mental illness and substance disorder: An overview. New Directions for Mental Health Services1991; 50:3–12.
25.
DrakeREOsherFCWallachMAAlcohol use and abuse in schizophrenia. A prospective community study. Journal of Nervous and Mental Disease1989; 177:408–414.
26.
CuffelBJChaseP.Remission and relapse of substance use disorders in schizophrenia. Results from a one-year prospective study. Journal of Nervous and Mental Disease1994; 182:342–348.
27.
GilbertPLHarrisMJMcAdamsLAJesteDVNeuroleptic withdrawal in schizophrenic patients: A review of the literature. Archives of General Psychiatry1995; 52:173–188.
28.
BaldessariniRJVigueraACNeuroleptic withdrawl in schizophrenic patients. Archives of General Psychiatry1995; 52:189–192.
29.
EreshefskyL.Pharmacokinetics and drug interactions: Update for new antipsychotics. Journal of Clinical Psychiatry1996; 57(Suppl. 11):12–25.
30.
JohnsonS.Dual diagnosis of severe mental illness and substance misuse: A case for specialist services?British Journal of Psychiatry1997; 171:205–208.
31.
OsherFCDixonLBHousing for persons with co-occurring mental and addictive disorders. New Directions in Mental Health Services1996; 70:53–64.
32.
OsherFCKofoedLLTreatment of patients with psychiatric and psychoactive substance abuse disorders. Hospital and Community Psychiatry1989; 40:1025–1030.
33.
LachanceKRSantosABModifying the PACT model: Preserving critical elements. Psychiatric Services1995; 46:601–604.